New York State Common Retirement Fund Paratek Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.73 - $3.09 $55,401 - $98,954	-32,024 Reduced 98.5%	489 $1,000
Q1 2022 May 05, 2022	SELL	$2.94 - $4.77 $193,746 - $314,343	-65,900 Reduced 66.96%	32,513 $97,000
Q4 2021 Feb 02, 2022	SELL	$4.07 - $5.3 $60,065 - $78,217	-14,758 Reduced 13.04%	98,413 $442,000
Q3 2021 Nov 02, 2021	BUY	$4.7 - $7.24 $432 - $666	92 Added 0.08%	113,171 $550,000
Q2 2021 Aug 02, 2021	SELL	$6.81 - $10.93 $145,018 - $232,754	-21,295 Reduced 15.85%	113,079 $771,000
Q1 2021 May 11, 2021	BUY	$6.14 - $8.31 $312,219 - $422,563	50,850 Added 60.88%	134,374 $949,000
Q4 2020 Feb 08, 2021	BUY	$4.58 - $7.14 $42,823 - $66,759	9,350 Added 12.61%	83,524 $523,000
Q1 2020 May 06, 2020	BUY	$2.67 - $4.97 $2,269 - $4,224	850 Added 1.16%	74,174 $234,000
Q4 2019 Feb 05, 2020	BUY	$2.93 - $4.5 $112,365 - $172,575	38,350 Added 109.65%	73,324 $295,000
Q3 2019 Nov 07, 2019	BUY	$3.08 - $5.76 $6,221 - $11,635	2,020 Added 6.13%	34,974 $151,000
Q2 2019 Aug 09, 2019	SELL	$3.47 - $6.32 $2,671 - $4,866	-770 Reduced 2.28%	32,954 $131,000
Q1 2019 May 08, 2019	SELL	$5.36 - $7.24 $4,288 - $5,792	-800 Reduced 2.32%	33,724 $181,000
Q4 2018 Feb 08, 2019	SELL	$4.8 - $11.6 $68,400 - $165,300	-14,250 Reduced 29.22%	34,524 $177,000
Q2 2018 Aug 10, 2018	BUY	$10.2 - $13.9 $12,954 - $17,653	1,270 Added 2.67%	48,774 $497,000
Q1 2018 May 10, 2018	BUY	$12.65 - $18.85 $219,110 - $326,500	17,321 Added 57.39%	47,504 $618,000
Q3 2017 Nov 06, 2017	SELL	$18.9 - $28.2 $174,182 - $259,891	-9,216 Reduced 23.39%	30,183 $758,000
Q2 2017 Aug 11, 2017	BUY	N/A	39,399	39,399 $950,000

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account